1. Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis. Issue 4 (18th March 2017) Authors: Tournadre, Anne; Pereira, Bruno; Dutheil, Fréderic; Giraud, Charlotte; Courteix, Daniel; Sapin, Vincent; Frayssac, Thomas; Mathieu, Sylvain; Malochet‐Guinamand, Sandrine; Soubrier, Martin Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 8:Issue 4(2017) Page Start: 639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Retention rates of adalimumab, etanercept and infliximab as first‐line biotherapy agent for rheumatoid arthritis patients in daily practice ‐ Auvergne experience. (13th September 2017) Authors: Soubrier, Martin; Pereira, Bruno; Frayssac, Thomas; Fan, Angelique; Couderc, Marion; Malochet‐Guinamand, Sandrine; Mathieu, Sylvain; Tatar, Zuzana; Tournadre, Anne; Dubost, Jean‐Jacques Journal: International journal of rheumatic diseases Issue: Volume 21:Number 11(2018) Page Start: 1924 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Retention rates of adalimumab, etanercept, and infliximab as first‐ or second‐line biotherapies for spondyloarthritis patients in daily practice in Auvergne (France). (30th August 2018) Authors: Soubrier, Martin; Pereira, Bruno; Fan, Angelique; Frayssac, Thomas; Couderc, Marion; Malochet‐Guinamand, Sandrine; Mathieu, Sylvain; Tatar, Zuzana; Tournadre, Anne; Dubost, Jean‐Jacques Journal: International journal of rheumatic diseases Issue: Volume 21:Number 11(2018) Page Start: 1986 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗